A Randomized, Multicenter, Open Label Study of MM-302 pl

Project: Research project

Description

A Randomized, Multicenter, Open Label Study of MM-302 plus Trastuzumab vs. Chemotherapy of Physicians Choice plus Trastuzumab in Anthracycline Naive Patients with Locally Advanced/Metastatic HER2-Positive Breast Cancer
StatusActive
Effective start/end date11/30/1411/30/19

Funding

  • Merrimack Pharmaceuticals, Inc

Fingerprint

Anthracyclines
Breast Neoplasms
Physicians
Drug Therapy
Trastuzumab